WRONG TECHNIQUE IN PRODUCT USAGE PROCESS

This adverse event was reported 202842 times

These drugs are most commonly taken by patients reporting WRONG TECHNIQUE IN PRODUCT USAGE PROCESS:

# Drug Count
0 EVOLOCUMAB 22690
1 ALBUTEROL SULFATE 19096
2 ADALIMUMAB 12264
3 PEGFILGRASTIM 10265
4 ETANERCEPT 10153
5 ERENUMAB-AOOE 9519
6 SACUBITRIL AND VALSARTAN 7341
7 LEUPROLIDE ACETATE 5625
8 ORAL SEMAGLUTIDE 3100
9 ACETAMINOPHEN 3009
See all common drugs associated with WRONG TECHNIQUE IN PRODUCT USAGE PROCESS

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEGFILGRASTIM 10265 0.8570
1 NORELGESTROMIN AND ETHINYL ESTRADIOL 344 0.1844
2 ERENUMAB-AOOE 9519 0.1713
3 EVOLOCUMAB 22690 0.1375
4 ESTRADIOL AND LEVONORGESTREL 265 0.1285
5 ERGOCALCIFEROL 2864 0.0963
6 LEUPROLIDE ACETATE 5625 0.0720
7 CENEGERMIN-BKBJ 949 0.0703
8 LOTILANER OPHTHALMIC SOLUTION 252 0.0643
9 ALBUTEROL SULFATE 19096 0.0637
See all drugs enriched for association with WRONG TECHNIQUE IN PRODUCT USAGE PROCESS

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Ectoparasiticide [EPC] 252 0.0643
1 Semifluorinated Alkane [EPC] 94 0.0404
2 mu-Opioid Receptor Agonist [EPC] 108 0.0366
3 Vasopressin V2 Receptor Antagonist [EPC] 535 0.0358
4 Opioid Antagonist [EPC] 34 0.0354
5 Cholinergic Nicotinic Agonist [EPC] 1813 0.0296
6 Angiotensin 2 Receptor Blocker [EPC] 8726 0.0273
7 Insulin [EPC] 1201 0.0259
8 Parathyroid Hormone-Related Peptide Analog [EPC] 767 0.0247
9 Pyrethroid [EPC] 40 0.0227
See all drug classes enriched for association with WRONG TECHNIQUE IN PRODUCT USAGE PROCESS